Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

NCT06644404 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DWP16001 0.3mg
DRUG: DWC202407 1,000mg
DRUG: DWC202408 2mg

Sponsor

Daewoong Pharmaceutical Co. LTD.